Loading patent…
AssigneesPeking University Shenzhen Graduate School, Cns Biotek Corp., Gansu Evergreen Pharmaceuticals Co.,Ltd.
InventorsZhen Yang, Yew-Min Tzeng, Linqi Zhang, Junmin Quan, Qing Chang, Qi Zhang, Chien-Ming Lee
Estimating the term…
A compound of Formula I compound—Ovatodiolide which is safe and effective to use in a pharmaceutical composition for inhibition of SARS-CoV-2 is provided. The pharmaceutical composition comprising a safe and effective amount of a compound of Formula I compound—Ovatodiolide or pharmaceutically acceptable salts thereof, together with a pharmaceutically acceptable carrier, which has great potential to treat SARS-CoV-2 induced COVID-19 based on a safe and effective amount of a compound of Formula I compound—Ovatodiolide.
A method for inhibiting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which comprises administering a safe and effective amount of Formula I compound—Ovatodiolide or a safe and effective amount of structural isomer of the Formula I compound—Ovatodiolide to a subject,
(canceled)
(canceled)
A method for inhibiting coronavirus which comprises administering a safe and effective amount of Formula I compound—Ovatodiolide, or a safe and effective amount of structural isomer of the Formula I compound—Ovatodiolide to a subject.
Dependencies are inferred from the claim text.